Combining magnetic and direct current transcranial stimulations was more effective than either treatment alone for major ...

BrainsWay Deep TMS is not currently cleared by the FDA for the safe or effective treatment of neuropathic pain. Additional outcomes from research conducted on these and other neuropathic pain patients ...

Repetitive transcranial magnetic stimulation offers rapid depression relief for patients unresponsive to conventional ...

The therapy is also indicated as an adjunct for the treatment of obsessive-compulsive disorder (OCD) in adults. The Horizon 3.0 Transcranial Magnetic Stimulation (TMS) Therapy System is a computerized ...

Clearance paves the way for the use of the TMS technology to treat patients with major depressive disorder (MDD), ...

The Horizon® 3.0 Inspire has a compact design allowing for easier portability. The Food and Drug Administration (FDA) has cleared Magstim’s Horizon ® 3.0 Inspire for the treatment of major ...

The Horizon® 3.0 Inspire has a compact design allowing for easier portability. The Food and Drug Administration (FDA) has cleared Magstim’s Horizon ® 3.0 Inspire for the treatment of major ...

Mental health is a vital aspect of overall well-being, especially for students who face unique pressures and challenges. From ...

MINNEAPOLIS and CARMARTHENSHIRE, United Kingdom, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Magstim, the global leader in neuroscience ...

2024 / Rapid Targeted Transcranial Magnetic Stimulation (TMS), a groundbreaking new treatment for depression, will now be available at The Menninger Clinic's Center for Brain Stimulation.

12, 2024 (GLOBE NEWSWIRE) -- Magstim, the global leader in neuroscience research and treatment ... transcranial magnetic stimulation technology to treat patients with MDD, OCD and Anxious Depression*.